Chutianpai Biotechnology (Changsha) Co., Ltd. (referred to as Chutianpai) is a subsidiary of Chutianpai Technology Co., Ltd. (stock code: 300358), a joint venture between Chutianpai Technology and PSI Peptide Technology Co., Ltd. in the United States, providing comprehensive peptide synthesis solutions and services for global peptide research and development institutions and production enterprises.

As one of the earliest companies in the world to provide peptide synthesis equipment, Chutian Pet has over 20 years of industry experience and profound accumulation of peptide technology. Relying on Chutian's strong manufacturing and delivery capabilities and industrial equipment technology, we form a strong alliance to meet customers' high demand for customized needs. According to different customer needs, various mixing methods can be used to achieve the most ideal homogeneous reaction, thereby achieving higher purity, and advanced GMP synthesis solutions can be equipped with closed inlet and outlet, online drying and other technologies. Chutianpai has become one of the few suppliers providing peptide synthesis solutions to globally renowned peptide pharmaceutical companies and top research institutions.